Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementing the 6th Generation Cardiac Troponin T: A Stepped Wedged Cluster-randomized Trial

NCT07936630 is registered in ClinicalTrials.gov with Rasmus Bo Hasselbalch as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07936630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Implementing the 6th Generation Cardiac Troponin T: A Stepped Wedged Cluster-randomized Trial
Lead sponsor
Rasmus Bo Hasselbalch
Phase
Not applicable
Overall status
Recruiting
Start date
August 1, 2026
Completion date
July 31, 2028
Enrollment
22,600 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

acs (acute coronary syndrome), mi(myocardial infarction)

Arms

As registered; 2 arms.

  • 5th generation cardiac troponin T arm Active comparatorStandard arm (5th generation of troponin T)

    Treatment is based on the use of the 5th generation troponin T assay

  • 6th generation cardiac troponin T arm ExperimentalUse of the 6th generation of cardiac troponin T assay

    Treatment is based on the use of the new 6th generation troponin T assay

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Composite endpoint of death from any cause and MI, or revascularization within 6 months after admission (PCI and CABG). 6 months

    This will exclude events during the index admission

Similar trials

Same condition (Acute Coronary Syndrome) and phase, most recent start first.